Savaria (FRA:S97) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:S97 Savaria Corp FRA:S97
89 GF Score
Price €18.90
GF Value €12.37
! 6 Warning Signs
View Full Analysis

What is Savaria FFO?

FFO (Funds from operations) only applies to REITs.

FRA:S97
89GF Score
Savaria Corp FRA:S97
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Savaria (FRA:S97) Overvalued in 2026?

Based on GuruFocus' analysis, Savaria stock appears to be overvalued. The current stock price of €18.90 is trading 52.8% above its estimated GF Value™ of €12.37.

Key valuation signals for FRA:S97:

  • FFO:
  • GF Value™: €12.37 vs. price of €18.90 (52.8% above fair value)
  • GF Score™: 89/100 with 6 warning signs

No single metric tells the full story. See the FRA:S97 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Savaria Business Description

Other Exchanges SISXF:USASIS:Canada
Address 4350 Autoroute Chomedey, Laval, QC, CAN, H7R 6E9
Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company's operating segments are Accessibility and Patient Care. The Accessibility segment deals with manufacturing, designing, installing, and distributing elevators, platform lifts, and stairlifts for people with mobility challenges. The Patient Care segment includes the manufacturing and distribution of a comprehensive line of therapeutic support surfaces and other pressure management products for the medical market. The company derives maximum revenue from Accessibility segment.
89GF Score

Get the complete analysis for FRA:S97

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.90
Price
€12.37
GF Value